BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan S, Sharaf M, Ahmed I, Khan TU, Shabana S, Arif M, Kazmi SSUH, Liu C. Potential utility of nano-based treatment approaches to address the risk of Helicobacter pylori. Expert Rev Anti Infect Ther 2021;:1-18. [PMID: 34658307 DOI: 10.1080/14787210.2022.1990041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Q, Wang W, Zhou S, Su J, Sun H, Zhai J, Hu Y. Jinghua Weikang capsule for helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis. Front Pharmacol 2022;13:959184. [DOI: 10.3389/fphar.2022.959184] [Reference Citation Analysis]
2 Jampilek J, Kralova K. Advances in Nanostructures for Antimicrobial Therapy. Materials (Basel) 2022;15:2388. [PMID: 35407720 DOI: 10.3390/ma15072388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Sharaf M, Arif M, Hamouda HI, Khan S, Abdalla M, Shabana S, Rozan HE, Khan TU, Chi Z, Liu C. Preparation, urease inhibition mechanisms, and anti-Helicobacter pylori activities of hesperetin-7-rhamnoglucoside. Curr Res Microb Sci 2022;3:100103. [PMID: 35024644 DOI: 10.1016/j.crmicr.2021.100103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]